1. Aimmune Therapeutics was the company behind this development. Their stock price at the beginning of 2019 was $24.34/share. In 2020 Nestle acquired Aimmune (they actually purchased the rest of the company they did not already own). Nestle agreed to purchase all of the then outstanding stock for $34.50 per share. If you had purchased Aimmune shares at the beginning of 2019 and then sold your shares to Nestle for their offer price, what would your total return have been on this investment (in dollars and as a percent)?